stockrow
Friday 6 November 2026
Export DYN’s income statement to Excel — free account
Dyne Therapeutics, Inc.
- EPS
- −11.3%
- Free cash flow
- −39.1%
- Total debt
- +116.0%
Quarter to June 2026, against a year earlier
18.06
0.70
+4.03%
Follow DYN
Alert me
Dyne Therapeutics, Inc. (DYN) Operating cash flow
Dyne Therapeutics, Inc.'s operating cash flow for fiscal 2025 was −$403.2M, compared with −$292.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$477.8M. Over the past ten years it has ranged from −$403.2M (fiscal 2025) to −$4.2M (fiscal 2018) — the current reading is the lowest in ten years. Operating cash flow has fallen for 7 consecutive fiscal years. Dyne Therapeutics, Inc. ranks 594th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$403.2M | — |
| FY2024 | −$292.4M | — |
| FY2023 | −$188.2M | — |
| FY2022 | −$153.6M | — |
| FY2021 | −$119.6M | — |
| FY2020 | −$46.5M | — |
| FY2019 | −$11.8M | — |
| FY2018 | −$4.2M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | −$130.3M | — |
| Mar 2026 | −$144.9M | — |
| Dec 2025 | −$111.8M | — |
| Sep 2025 | −$90.8M | — |
| 24 more quarters | Free account |
Against its own ten years
Low −$403.2M
High −$4.2M
Ten-year median
−$136.6M
Current reading's percentile
13
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ACAD ACADIA Pharmaceuticals Inc. compare | $97.5M |
| TLX Telix Pharmaceuticals Limited compare | $51.9M |
| TARS Tarsus Pharmaceuticals, Inc. compare | $49.9M |
| ELVN Enliven Therapeutics, Inc. compare | −$66.9M |
| CELC Celcuity, Inc. compare | −$191.7M |
| VRDN Viridian Therapeutics, Inc. compare | −$341.5M |
| DNLI Denali Therapeutics Inc. compare | −$444.2M |
| VKTX Viking Therapeutics, Inc. compare | −$462.6M |
| DYN Dyne Therapeutics, Inc. | −$477.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item